Cargando…

The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation

Introduction: In recent years, purinergic signaling via the P2X7 receptor (P2X7R) on microglia has repeatedly been implicated in depression genesis. However, it remains unclear which role the human P2X7R (hP2X7R) plays in regulating both microglia morphology and cytokine secretion upon different env...

Descripción completa

Detalles Bibliográficos
Autores principales: von Mücke-Heim, Iven-Alex, Martin, Jana, Uhr, Manfred, Ries, Clemens, Deussing, Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123291/
https://www.ncbi.nlm.nih.gov/pubmed/37101546
http://dx.doi.org/10.3389/fphar.2023.1148190
_version_ 1785029642673979392
author von Mücke-Heim, Iven-Alex
Martin, Jana
Uhr, Manfred
Ries, Clemens
Deussing, Jan M.
author_facet von Mücke-Heim, Iven-Alex
Martin, Jana
Uhr, Manfred
Ries, Clemens
Deussing, Jan M.
author_sort von Mücke-Heim, Iven-Alex
collection PubMed
description Introduction: In recent years, purinergic signaling via the P2X7 receptor (P2X7R) on microglia has repeatedly been implicated in depression genesis. However, it remains unclear which role the human P2X7R (hP2X7R) plays in regulating both microglia morphology and cytokine secretion upon different environmental and immune stimuli, respectively. Methods: For this purpose, we used primary microglial cultures derived from a humanized microglia-specific conditional P2X7R knockout mouse line to emulate different gene-environment interactions between microglial hP2X7R and molecular proxies of psychosocial and pathogen-derived immune stimuli. Microglial cultures were subjected to treatments with the agonists 2′(3′)-O-(4-benzoylbenzoyl)-ATP (BzATP) and lipopolysaccharides (LPS) combined with specific P2X7R antagonists (JNJ-47965567, A-804598). Results: Morphotyping revealed overall high baseline activation due to the in vitro conditions. Both BzATP and LPS + BzATP treatment increased round/ameboid microglia and decreased polarized and ramified morphotypes. This effect was stronger in hP2X7R-proficient (CTRL) compared to knockout (KO) microglia. Aptly, we found antagonism with JNJ-4796556 and A-804598 to reduce round/ameboid microglia and increase complex morphologies only in CTRL but not KO microglia. Single cell shape descriptor analysis confirmed the morphotyping results. Compared to KO microglia, hP2X7R-targeted stimulation in CTRLs led to a more pronounced increase in microglial roundness and circularity along with an overall higher decrease in aspect ratio and shape complexity. JNJ-4796556 and A-804598, on the other hand, led to opposite dynamics. In KO microglia, similar trends were observed, yet the magnitude of responses was much smaller. Parallel assessment of 10 cytokines demonstrated the proinflammatory properties of hP2X7R. Following LPS + BzATP stimulation, IL-1β, IL-6, and TNFα levels were found to be higher and IL-4 levels lower in CTRL than in KO cultures. Vice versa, hP2X7R antagonists reduced proinflammatory cytokine levels and increased IL-4 secretion. Discussion: Taken together, our results help disentangle the complex function of microglial hP2X7R downstream of various immune stimuli. In addition, this is the first study in a humanized, microglia-specific in vitro model identifying a so far unknown potential link between microglial hP2X7R function and IL-27 levels.
format Online
Article
Text
id pubmed-10123291
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101232912023-04-25 The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation von Mücke-Heim, Iven-Alex Martin, Jana Uhr, Manfred Ries, Clemens Deussing, Jan M. Front Pharmacol Pharmacology Introduction: In recent years, purinergic signaling via the P2X7 receptor (P2X7R) on microglia has repeatedly been implicated in depression genesis. However, it remains unclear which role the human P2X7R (hP2X7R) plays in regulating both microglia morphology and cytokine secretion upon different environmental and immune stimuli, respectively. Methods: For this purpose, we used primary microglial cultures derived from a humanized microglia-specific conditional P2X7R knockout mouse line to emulate different gene-environment interactions between microglial hP2X7R and molecular proxies of psychosocial and pathogen-derived immune stimuli. Microglial cultures were subjected to treatments with the agonists 2′(3′)-O-(4-benzoylbenzoyl)-ATP (BzATP) and lipopolysaccharides (LPS) combined with specific P2X7R antagonists (JNJ-47965567, A-804598). Results: Morphotyping revealed overall high baseline activation due to the in vitro conditions. Both BzATP and LPS + BzATP treatment increased round/ameboid microglia and decreased polarized and ramified morphotypes. This effect was stronger in hP2X7R-proficient (CTRL) compared to knockout (KO) microglia. Aptly, we found antagonism with JNJ-4796556 and A-804598 to reduce round/ameboid microglia and increase complex morphologies only in CTRL but not KO microglia. Single cell shape descriptor analysis confirmed the morphotyping results. Compared to KO microglia, hP2X7R-targeted stimulation in CTRLs led to a more pronounced increase in microglial roundness and circularity along with an overall higher decrease in aspect ratio and shape complexity. JNJ-4796556 and A-804598, on the other hand, led to opposite dynamics. In KO microglia, similar trends were observed, yet the magnitude of responses was much smaller. Parallel assessment of 10 cytokines demonstrated the proinflammatory properties of hP2X7R. Following LPS + BzATP stimulation, IL-1β, IL-6, and TNFα levels were found to be higher and IL-4 levels lower in CTRL than in KO cultures. Vice versa, hP2X7R antagonists reduced proinflammatory cytokine levels and increased IL-4 secretion. Discussion: Taken together, our results help disentangle the complex function of microglial hP2X7R downstream of various immune stimuli. In addition, this is the first study in a humanized, microglia-specific in vitro model identifying a so far unknown potential link between microglial hP2X7R function and IL-27 levels. Frontiers Media S.A. 2023-04-10 /pmc/articles/PMC10123291/ /pubmed/37101546 http://dx.doi.org/10.3389/fphar.2023.1148190 Text en Copyright © 2023 von Mücke-Heim, Martin, Uhr, Ries and Deussing. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
von Mücke-Heim, Iven-Alex
Martin, Jana
Uhr, Manfred
Ries, Clemens
Deussing, Jan M.
The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
title The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
title_full The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
title_fullStr The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
title_full_unstemmed The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
title_short The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
title_sort human p2x7 receptor alters microglial morphology and cytokine secretion following immunomodulation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123291/
https://www.ncbi.nlm.nih.gov/pubmed/37101546
http://dx.doi.org/10.3389/fphar.2023.1148190
work_keys_str_mv AT vonmuckeheimivenalex thehumanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT martinjana thehumanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT uhrmanfred thehumanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT riesclemens thehumanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT deussingjanm thehumanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT vonmuckeheimivenalex humanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT martinjana humanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT uhrmanfred humanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT riesclemens humanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation
AT deussingjanm humanp2x7receptoraltersmicroglialmorphologyandcytokinesecretionfollowingimmunomodulation